High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume 8, Issue 2, Pages 129-136
Publisher
Oxford University Press (OUP)
Online
2013-08-07
DOI
10.1016/j.crohns.2013.07.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis
- (2016) Remo Panaccione et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn’s disease
- (2013) W. J. Sandborn et al. CURRENT MEDICAL RESEARCH AND OPINION
- C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I
- (2012) W. Reinisch et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms
- (2012) I Ordás et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease
- (2011) L. S. Kiss et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
- (2011) Matthias Jürgens et al. Clinical Gastroenterology and Hepatology
- Pharmacokinetic Properties of Infliximab in Children and Adults with Crohn's Disease: A Retrospective Analysis of Data from 2 Phase III Clinical Trials
- (2011) Adedigbo A. Fasanmade et al. CLINICAL THERAPEUTICS
- Effect of adalimumab on clinical laboratory parameters in patients with Crohnʼs disease: Results from the CHARM trial
- (2011) David T. Rubin et al. INFLAMMATORY BOWEL DISEASES
- Predictors of Infliximab Failure After Azathioprine Withdrawal in Crohn's Disease Treated With Combination Therapy
- (2010) Abderrahim Oussalah et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies
- (2010) Diane R. Mould et al. BIODRUGS
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
- (2010) A. Dignass et al. Journal of Crohns & Colitis
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
- (2009) Adedigbo A. Fasanmade et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Biological Therapies for Inflammatory Bowel Diseases
- (2009) Paul Rutgeerts et al. GASTROENTEROLOGY
- Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis
- (2009) C H Seow et al. GUT
- C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study
- (2008) M Henriksen et al. GUT
- Predicting relapse in Crohn's disease: a biopsychosocial model
- (2008) A Bitton et al. GUT
- European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
- (2008) E.F. Stange et al. Journal of Crohns & Colitis
- C-reactive protein levels during a relapse of Crohn’s disease are associated with the clinical course of the disease
- (2008) Chantal L Koelewijn et al. WORLD JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search